ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 255,01
0,58%
Dow Jones
44 296,51
0,97%
DAX
19 322,59
0,91%
Brent Oil
74,65
0,00%
Bitcoin
98 626,03
-0,41%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aptose Biosciences Inc (APTO)

  7. Aptose Biosciences Inc (APTO) Actualités

APTO

Aptose Biosciences (APTO)

Aptose Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:APTO
DateHeureSourceTitreSymboleSociété
22/11/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
22/11/202414h00GlobeNewswire Inc.Aptose Biosciences Inc. Announces Pricing of $8 Million Public OfferingNASDAQ:APTOAptose Biosciences Inc
22/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APTOAptose Biosciences Inc
20/11/202413h30GlobeNewswire Inc.Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet TherapyNASDAQ:APTOAptose Biosciences Inc
14/11/202421h22Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:APTOAptose Biosciences Inc
08/11/202422h01GlobeNewswire Inc.Aptose Reports Results for the Third Quarter 2024NASDAQ:APTOAptose Biosciences Inc
31/10/202411h39Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APTOAptose Biosciences Inc
05/09/202422h15GlobeNewswire Inc.Aptose Announces Results from Special Meeting of ShareholdersNASDAQ:APTOAptose Biosciences Inc
30/08/202422h30GlobeNewswire Inc.Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop TuspetinibNASDAQ:APTOAptose Biosciences Inc
15/08/202422h30GlobeNewswire Inc.Aptose Announces Adjournment of its Special Meeting of ShareholdersNASDAQ:APTOAptose Biosciences Inc
08/08/202423h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APTOAptose Biosciences Inc
08/08/202423h06GlobeNewswire Inc.Aptose Reports Results for the Second Quarter 2024NASDAQ:APTOAptose Biosciences Inc
19/07/202423h00GlobeNewswire Inc.Aptose Announces Receipt of Deficiency Notice from NasdaqNASDAQ:APTOAptose Biosciences Inc
17/07/202417h43Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APTOAptose Biosciences Inc
03/06/202412h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:APTOAptose Biosciences Inc
10/05/202417h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
14/02/202422h51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APTOAptose Biosciences Inc
26/01/202423h30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APTOAptose Biosciences Inc
26/01/202403h44Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:APTOAptose Biosciences Inc
21/09/202323h10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APTOAptose Biosciences Inc
06/07/202322h01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:APTOAptose Biosciences Inc
26/06/202322h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTOAptose Biosciences Inc
20/06/202312h01Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APTOAptose Biosciences Inc
19/04/202312h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APTOAptose Biosciences Inc
03/04/202322h23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APTOAptose Biosciences Inc
24/03/202311h01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APTOAptose Biosciences Inc
14/02/202323h19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APTOAptose Biosciences Inc
17/01/202312h08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APTOAptose Biosciences Inc
12/12/202217h55TipRanksJonesTrading Keeps Their Buy Rating on Aptose Biosciences (APTO)NASDAQ:APTOAptose Biosciences Inc
17/11/202215h55TipRanksAptose Biosciences (APTO) Gets a Buy from H.C. WainwrightNASDAQ:APTOAptose Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:APTO

Dernières Valeurs Consultées

USOTC
TBEV
High Performance Beverages (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés

Vendredi fou

ADVFN

Célébrons nos 25 ans Est 1999-2024

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres
EU Flag

Cours Euronext en temps réel et illimités sur le site. Carnet d'ordres Euronext en direct